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Abstract
The mechanisms by which nitrous oxide (N2O) produces physical dependence and withdrawal seizures are not
well understood, but both N2O and ethanol exert some of their effects via the GABAA receptor and several lines
of evidence indicate that withdrawal from N2O and ethanol may be produced through similar mechanisms.
Expression levels of mRNA transcripts encoding several GABAA receptor subunits change with chronic ethanol
exposure and, therefore, we hypothesized that N2O exposure would produce changes in mRNA expression for
the α1 subunit. Male, Swiss–Webster mice, 10–12 weeks of age, were exposed for 48 h to either room air or a
75%:25% N2O:O2 environment. Brains were sectioned and mRNA for the α1 subunit was detected by in situ

hybridization using an 35S-labelled cRNA probe. N2O exposure produced a significant increase in expression
levels of the α1 subunit mRNA in the cingulate cortex, the CA1/2 region of the hippocampus, the dentate gyrus,
the subiculum, the medial septum, and the ventral tegmental area. These results lend support to the hypothesis
that N2O effects are produced, at least in part, through the GABAA receptor and that N2O produces these effects
through actions in the cingulate cortex, hippocampus, ventral tegmental area and medial septum. These results
are also further evidence that ethanol and N2O produce dependence and withdrawal through common
mechanisms.
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1. Introduction
Nitrous oxide (N2O) is an analgesic, anxiolytic, anesthetic drug with euphorogenic properties and abuse
potential. Animals with prolonged exposure to N2O experience physical dependence and withdrawal seizures
[3], [18], [31], [36], [50]. Although it is widely believed that nitrous oxide interacts with central opioid
mechanisms to produce its analgesic effect (for review see [48]) and through the GABAA receptor to produce its
anxiolytic effect [13], [45], [49], the mechanisms by which N2O produces physical dependence and withdrawal
seizures remain unclear.
Several lines of evidence indicate that withdrawal from N2O and ethanol may be produced through similar
mechanisms. Withdrawal from N2O and ethanol are both accompanied by withdrawal seizures [3], [18], [31],
[36], [50], [53]. N2O can suppress ethanol withdrawal seizures [3], ethanol can suppress N2O withdrawal seizures
[3], and cross-tolerance between N2O and ethanol has been demonstrated [22]. In addition, sensitivity of various
mouse strains to ethanol and N2O correlate well [3], [21], and quantitative trait loci analysis of BXD recombinant
inbred mouse strains demonstrates a genetic correlation between N2O and ethanol withdrawal [4].
Some of the effects of both N2O and ethanol, including anxiolytic effects and withdrawal symptoms, are known
to occur through interaction with the GABAA receptor. The anxiolytic effects of N2O are sensitive to antagonism
by the benzodiazepine antagonist flumazenil and the anxiolytic effects are significantly reduced in
benzodiazepine-tolerant animals [13], [45]. There is also evidence that withdrawal responses following exposure
to N2O involve the GABAA receptor. For example, injection of the benzodiazepine partial inverse agonist Ro 154513 significantly increased the frequency of withdrawal seizures in N2O-exposed mice [56], an effect also seen
with ethanol-induced withdrawal seizures [2], [27].
GABAA receptors are heterooligomeric complexes consisting of numerous isoforms of several classes of subunits
(α, β, γ, δ, ρ). Since recombinant expression studies have shown that the pharmacology and the binding
characteristics of GABAA receptor are altered by the expression of different subunit combinations [1], [7], [10],
[25], [28], [37], [38], [44], [51], [52], it has been hypothesized that one mechanism by which ethanol alters
GABAA receptor function is by differentially affecting the expression of GABAA receptor subunits and thus
altering the composition of GABAA receptors and their responsiveness to GABA [34], [39], [41]. Expression levels
of mRNA transcripts encoding several GABAA receptor subunits are altered by chronic ethanol exposure, with
consistent findings of decreased mRNA expression for the α1 subunit in rat cortex following chronic ethanol
exposure [8], [12], [32], [33], [34], [39], [41]. A number of studies have detected changes in other subunits of the
GABAA receptor in either rat cortex and cerebellum following chronic ethanol, including changes in α2–6, [8], [11],
[12], [33], [34], [39], β1–3[11], [35], and γ1[11], [12], with others reporting no differences in expression of α3[34],
[39], α5[12] or β1–3[12], [40]. However, relatively few studies have examined brain regions other than cortex or
cerebellum. These studies have found that durations longer than the typical 2 weeks of ethanol exposures are

necessary to produce changes in GABAA receptor subunit composition. Forty days of chronic ethanol
consumption were necessary to produce an increase in the α4 subunit peptide in hippocampus [32]. Gene
expression for the hippocampal α1, α2, α3, β2/3 or γ2 subunits was unchanged at that time. Others found that a
12-week, but not 4-week, ethanol exposure induced changes in α1 and α5 subunit expression in the
hippocampus and α1 subunit levels in the ventral tegmental area [8], [42]. No changes were found in nucleus
accumbens or substantia nigra [8].
Results of ethanol exposure on GABAA receptor subunit composition in mouse brain have been mixed, with
results largely dependent upon mouse strain and brain region. For instance, following ethanol treatment,
expression of whole brain α1 mRNA was found to be decreased in Withdrawal Seizure Prone (WSP) and
unchanged in Withdrawal Seizure Resistant (WSR) mice [6] but increased in ddy mice [19]. On the other hand, α1
mRNA expression was reportedly increased in the cerebellum but decreased in the whole brains of C57BL/6J
(C6) mice [60]. Levels of α6 mRNA were decreased in WSR mice, unchanged in WSP mice [6], and increased in C6
mice [60]. Levels of γ2 mRNA were increased by ethanol in C6 mice [60] but not WSP or WSR mice [6].
Because both N2O and ethanol exert some of their effects via the GABAA receptor, and evidence indicates that
ethanol and N2O produce dependence and withdrawal through similar mechanisms, we investigated the effect
of N2O exposure on mRNA expression for the α1 subunit of the GABAA receptor.
Further, we felt it important to conduct an extensive neuroanatomical study, both because multiple brain
regions are thought to be important in the development of drug dependency and withdrawal responses, and
because of the wide-ranging effects of N2O on the brain. Previous work has shown that withdrawal seizures can
be evoked following durations of N2O exposures ranging from 30 min to 48 h (62). For this neuroanatomical
study of the distribution of N2O-induced changes in mRNA expression, a 48-h duration was chosen to maximize
opportunity for alterations mRNA expression levels.

2. Materials and methods
2.1. Nitrous oxide exposure

Male, Swiss–Webster mice (Charles River, Portage, MI), 10–12 weeks of age, were exposed for 48 h to either
room air or a 75%:25% N2O:O2 environment. Three cages of five mice were placed in a modified infant incubator
[26] with a N2O delivery rate of 6 liter/min and an O2 delivery rate of 1.5 liter/min. Gases were delivered using a
standard nitrous oxide/oxygen anesthesia machine (Adec, Newburg, Oregon). The exhausted gas was vented to
a nearby fumehood. Mice were removed from the N2O, left in room air for 10 minutes and sacrificed by rapid
decapitation. Whole brains were immediately removed, frozen in isopentane at −40°C for 30 s, wrapped in
parafilm, and stored at −70°C

2.2. In situ hybridization
2.2.1. Tissue fixation

Serial cryostat sections of brain (14 μm) were mounted on polylysine-coated slides and stored at −70°C until use.
Slices were fixed in 4% buffered paraformaldehyde for 2 h and washed four times with 2×SSC (saline–sodium
citrate buffer) (pH=7.4). Tissue sections were treated with proteinase K (0.1 μg/ml) for 8 min at 37°C, washed
with distilled water and rinsed with 2×SSC. Slides were subsequently acetylated with 0.25% acetic anhydride in a
0.1 M triethanolamine buffer (pH=8.0) for 15 minutes. Finally, slides were washed in 2×SSC three times and
dehydrated in a successive series of alcohols.

2.2.2. Probe labeling

A riboprobe complementary to mRNA transcript encoding the α1 subunit of the GABAA receptor was synthesized
according to standard in vitro transcription methodology. Briefly, a cRNA probe was generated in a reaction

(total volume=10 μl) containing 125 μCi 35S UTP (Amersham, 20 μCi/ml), 1 μl each of 10 mM stocks of ATP, CTP,
and GTP, 2 μl 5×transcription buffer, 1 μl 0.1 M dithiothreitol, 1 μl linearized plasmid DNA (1 μg/μl), 1 μl distilled
water, 0.5 μl of RNase inhibitor (40 U/μl), and 1.5 μl T7 polymerase. The reaction was allowed to proceed at
37°C for 2 h followed by separation of labeled probe from reaction contents on a G50-sephadex column. Probes
were diluted in hybridization buffer (Amresco, Solon, OH) consisting of 45% formamide, 10% dextran sulfate,
3×SSC, 50 mM sodium phosphate buffer (pH=7.4), 1×Denhardt’s solution, 0.1 mg/ml sheared salmon sperm
DNA, and 0.1 mg/ml yeast, to yield approximately 1 500 000 cpm/35 μl buffer. The GABAA-receptor cDNA was
kindly provided by Dr. A. Tobin (UCLA) and was subcloned into PGem3Z and linearized with Hind III to transcribe
a cRNA probe of 842 nts.

2.2.3. Hybridization histochemistry

Tissue sections were apposed to coverslips containing 35 μl probe and stored for 15 h at 55°C in sealed
chambers moistened with a 45% formamide solution. Following hybridization, coverslips were removed in
2×SSC, the slides were washed extensively in 2×SSC and then treated with RNase A (200 μg/ml) in Tris buffer for
90 minutes at 37°C. This was followed by several rinses in decreasing concentrations of SSC (2×SSC, 1×SSC,
0.5×SSC, and 0.2×SSC), and washing at 65°C for 1 h in 0.2×SSC. Slides were then washed in 0.2×SSC at room
temperature and dehydrated through graded alcohol concentrations. Slides were exposed to Kodak BioMax Xray film for 16 h and developed in GBX developer.

2.2.4. Imaging

X-ray images were digitized and analyzed using NIH Image software. Identification of brain regions was
determined using the atlas of Franklin and Paxinos [14]. Depending on the size of the brain region of interest,
between 3 and 80 gray value signals for each specific brain region were obtained per mouse (n=5 control mice,
n=8 N2O exposed mice). Mean gray values were determined for each brain region per mouse after subtraction of
background values determined from adjacent brain regions which lacked specific expression of the GABAA
receptor.

2.3. Statistics

Two-way analysis of variance was performed to test whether there were differences in mean gray values in 20
brain regions between N2O and room air exposed mice. To correct for heteroscedasticity, the data was
transformed using the equation
[62]. Post-hoc analysis to determine which brain regions accounted for the statistically significant main effect
seen in treatment groups was performed using the Tukey multiple comparison test.

3. Results

The regional expression pattern of the α1 subunit mRNA was similar to that previously found in rat [29], [30],
[43], [57] and long-sleep and short-sleep mouse brain [61]. Widespread distribution was noted, with highest
expression densities in the cerebellar Purkinje layer and the ventral tegmental nucleus, high levels in the cortical
primary and secondary somatosensory cortex, dense layer of the piriform cortex, CA1/2 region of the
hippocampus and subiculum, granular layer of the cerebellum, red nucleus and the medial septum. Moderate to
high levels were found in the cingulate and motor cortex, CA3 region of the hippocampus, dentate gyrus,
molecular layer of the cerebellum, and globus pallidus. Low to moderate levels were found in the basolateral,
medial and central amygdaloid nucleus, and ventral tegmental area (VTA) (Fig. 1). The regional distribution of
the GABAA receptor α1 subunit mRNA in N2O and room air exposed mice is shown in Fig. 2, Fig. 3.

Fig. 1. Regional distribution of expression of GABAA α1 subunit mRNA in control mice. Mean gray values,
determined from multiple sections for each specific brain region, were determined for each mouse. The average
mean gray values for 5 control mice±S.E.M. are plotted.

Fig. 2. Darkfield photomicrographs of coronal sections at three forebrain levels illustrate the brain distribution of
mRNA transcripts encoding the α1 subunit of the GABAA receptor in mice exposed to room air (A–E) or 75% N2O
(B–F) for 48 h. Abbreviations: ac, anterior commissure; BL, basolateral amygdaloid nucleus; CA1, CA3,
hippocampal subfields; CE, central amygdaloid nucleus; Cg, cingulate gyrus; Co, cortical amygdaloid nucleus; CP,

caudate putamen; DG, dentate gyrus; GP, globus pallidus; HDB, horizontal limb of the diagonal band nucleus; ic,
internal capsule, LS, lateral septal nucleus; Me, medial amygdaloid nucleus; MS, medial septal nucleus; Par,
parietal cortex, Pir, piriform cortex; VDB, vertical limb of the diagonal band nucleus, 3V, third ventricle.

Fig. 3. Darkfield photomicrographs of coronal sections at three brainstem levels illustrate the brain distribution
of mRNA transcripts encoding the α1 subunit of the GABAA receptor in mice exposed to room air (A, C, E) or 75%
N2O (B, D, F) for 48 h. Abbreviations: Aq, cerebral aqueduct; gl, granular layer, cerebellum; IC, inferior colliculus;
LV, lateral vestibular nucleus; MG, medial geniculate nucleus; ml, molecular layer, cerebellum; MV, medial
vestibular nucleus; pl, purkinje layer, cerebellum; py, pyramidal tract; RN, red nucleus; SN, substantia nigra; Sub,
subiculum; VTA, ventral tegmental area; Vtg, ventral tegmental nucleus; 4V, fourth ventricle; 7, facial nucleus.
Exposure of mice to 48 h of 75% N2O produced a statistically significant increase in expression levels of mRNA
for the α1 subunit of the GABAA receptor (P<0.001, two-way ANOVA). There was also a statistically significant
difference in expression levels of mRNA between brain regions (P<0.001) and a statistically significant
interaction between treatment and brain region (P
0.023). Post-hoc statistical analysis using the Tukey test
found significant increases following N2O exposure in the cingulate cortex (P0.002), the CA1/2 region of the
hippocampus (P0.005), the dentate gyrus (P0.042), the subiculum (P0.047), the medial septum (P0.004),
and the ventral tegmental area (P
0.034) (Table 1).
Table 1. The effect of nitrous oxide exposure on GABAA α1 subunit mRNA expressiona
Brain region
Cingulate cortex
Motor cortex
Primary somatosensory cortex
Secondary somatosensory cortex
Piriform cortex
CA1/2 region, Hippocampus
CA3 region, Hippocampus
Dentate gyrus
Subiculum
Medial septum
Ventral tegmental area
Purkinje layer, cerebellum

Room air exposure
27.90±1.09
29.66±0.60
41.46±0.63
43.73±0.71
56.80±1.38
39.11±3.63
19.44±2.22
27.58±2.28
40.50±5.46
42.04±1.55
0.76±0.40
109.00±2.96

N2O exposure
38.03±1.68
35.44±0.90
46.92±1.10
44.50±1.27
61.51±2.67
49.85±2.74
25.09±1.85
34.08±1.78
47.76±3.04
53.77±2.57
2.43±0.47
116.74±3.76

% change
36.3
19.5
13.2
1.8
8.3
27.5
29.1
23.6
17.9
27.9
219.7
7.1

Significance
P=0.002**
P=0.082
P=0.167
P=0.851
P=0.308
P=0.005**
P=0.214
P=0.042*
P=0.047*
P=0.004**
P=0.034*
P=0.228

Granular layer, cerebellum
47.20±3.42
49.55±3.82
5.0
P=0.618
Molecular layer, cerebellum
18.23±2.21
17.23±1.98
−5.5
P=0.672
Basolateral amygdaloid nucleus
12.08±3.11
12.31±0.78
1.9
P=0.682
Medial amygdaloid nucleus
6.07±1.51
7.39±0.91
21.7
P=0.279
Central amygdaloid nucleus
1.62±0.79
0.50±0.35
−69.1
P=0.050
Red nucleus
46.19±2.99
42.10±3.23
−8.9
P=0.278
Ventral tegmental nucleus
87.20±4.6
83.58±5.06
−4.2
P=0.484
Globus pallidus
21.75±1.67
22.91±1.16
5.3
P=0.666
a. Levels of expression were measured using computerized image analysis and mean gray values were calculated
from multiple sections throughout each region for each mouse. Data are reported as the average mean gray
values±S.E.M. for mice exposed to room air (n=5) or nitrous oxide (n=8).
*Statistical significance was determined by the Tukey multiple comparison test following two-way analysis of
variance. *P<0.05; **P≤0.005.

4. Discussion
The present studies are the first to identify specific brain regions affected by N2O exposure and indicate an up
regulation of GABAA α1 subunit mRNA in the cingulate cortex, the hippocampus, the medial septum, and the
VTA. Interestingly, these brain regions have all been implicated as sites of action of ethanol, and ethanolinduced changes in GABAA receptor subunit expression have been identified in the cortex, hippocampus and
VTA. Further, the VTA, as part of the mesolimbic dopaminergic pathway, has long been thought to be involved in
the reinforcing actions of drugs of abuse, including ethanol [23], [24], [58], [59]. Ethanol can stimulate the
activity of VTA dopaminergic neurons, and has been found to be reinforcing when administered directly into the
VTA in operant conditioning experiments [15]. Mesolimbic GABAergic systems are also thought to be involved in
the ethanol reinforcement properties, since muscimol injected into the VTA was shown to alter ethanolreinforced responding [20].
Actions of ethanol and N2O on the GABAergic system of the medial septum may be of particular functional
importance. While the effects of ethanol on GABAA receptor subunit composition in the medial septum have not
been investigated, other effects of ethanol on this brain region have been extensively examined. The medial
septum has been implicated as a brain region that influences the ethanol-induced impairment of nonspatial
working memory [17] and depression of locomotion [5], as well as the sedative action of ethanol, enhancing the
GABA-mediated inhibition of medial septal neuronal activity [16], [54]. Chronic ethanol exposure also produces
long term effects on the septal GABAergic system, decreasing GABA’s ability to inhibit ethanol-sensitive cells in
the medial septum after ethanol withdrawal [9]. Thus, the changes in GABAA α1 subunit expression observed in
the present study both support the hypothesis that N2O effects are mediated, at least in part, through GABAA
receptors and provide further evidence for similar mechanisms of action of N2O and ethanol.
Importantly, the increases in GABAA α1 subunit expression detected in the present study were not generalized to
all regions under investigation. Areas examined in which differences could not be detected included the
cerebellum, globus pallidus, red nucleus, basolateral and medial amygdaloid nuclei, as well as cortical areas such
as the somatosensory and the piriform cortices. Interestingly, within the hippocampal formation, an upregulation of α1 subunits was noted within the dentate gyrus, CA1 and subiculum, but not in CA3, further
suggesting the site-specific nature of the experimental effect. Moreover, regions in which increases were
detected have all been implicated in aspects of ethanol addiction/withdrawal. If the present mRNA changes are
indeed paralleled by similar increases at the protein level, the findings provide further evidence for a prominent
role for GABAergic mechanisms in the reinforcing properties of N2O and ethanol, and may yield insights into the
sequence of cellular events underlying these processes.

The increase in α1 subunit mRNA levels seen following N2O exposure may reflect a generalized increase in the
concentration of GABAA receptors. It is also possible that N2O exposure causes a modification of receptor
composition, with an increase in the proportion of GABAA receptors containing the α1 subunit. There is evidence
that ethanol can produce such an effect in rat cortex, where it has been shown that exposure to ethanol results
in a decrease in α1 subunit mRNA and protein approximately equal to the increase in the α4 subunit mRNA and
protein [11], [12]. A similar effect was found in the hippocampus, where long term administration of ethanol
produced a decrease α1 subunit mRNA and an increase in α5 mRNA levels [8]. Such a change in subunit
composition, with or without a change in the overall number of GABAA receptors, could significantly change
GABAA receptor function, since the pharmacology and the binding characteristics of GABAA receptor have been
shown to be influenced by expression of different GABAA receptor subunit combinations [1], [7], [10], [25], [28],
[37], [38], [44], [51], [52]. Moreover, an increase in mRNA expression for the α1 subunit produced by ethanol
exposure in mice was previously shown to correspond to a decrease in GABA-dependent Cl− flux [19]. The
functional impact of N2O-induced increases in the α1 mRNA expression might similarly alter the efficacy of
GABAergic inhibition. It should be noted, however, that N2O-induced changes in mRNA levels for α1 subunit may
not correlate with changes in protein and/or changes in GABAA receptor stoichiometry.
The functional significance of the changes in GABAA receptor subunit expression produced by N2O remains to be
determined. Mouse strain has been shown to be an important variable in responsiveness to both the analgesic
effects of N2O [46], [47] and the ability of N2O to induce withdrawal seizures [55]. Moreover, ethanol studies
have shown that mouse strain can influence the effect of ethanol on GABAA receptor subunit expression [6],
[19], [60]. Therefore, determining the effect of N2O on GABAA receptor subunit expression in other mouse
strains is an important consideration in the analysis of the functional impact of N2O-induced changes in the
GABAA receptor. In addition, results of previous ethanol studies have shown that effects on GABAA receptor
subunit expression vary with the duration of drug exposure. Expression of α1, α6, β3 and γ2 subunits were
differentially affected by acute and chronic ethanol administration [60] and varying durations of chronic ethanol
exposures were necessary for changes in GABAA receptor subunit expression in different brain regions [8], [42].
Varying the duration of N2O exposure may also provide insight into the functional impact of N2O-induced
changes in the GABAA receptor.
The N2O-induced increase in GABAA receptor α1 subunit mRNA expression found in the present experiments
supports the hypothesis that N2O effects are produced, at least in part, through the GABAA receptor, and localize
the N2O-induced effects to the cingulate cortex, hippocampus, ventral tegmental area and medial septum. These
results are also consistent with the hypothesis that ethanol and N2O produce dependence and withdrawal
through common mechanisms. Future studies on the effect of N2O on the full complement of subunits of the
GABAA receptor, as well as additional receptor types, will be required for a more complete understanding of the
neuronal mechanism of action of N2O.
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